Prot #CLCI699C2201: A Proof-of Concept, Open-Label, Forced Titration, Multi-Center Study to Assess the Safety/Tolerability and Efficacy of 10-Weeks Treatment of LCI699 Followed by a 12 Week Treatment Period in Patients with Cushing's Disease.